Prediction of HIV-1 coreceptor usage (Tropism) by sequence analysis using a genotypic approach

Journal of Visualized Experiments

Volumn , Issue 58, 2011, Pages

  Sierra, Saleta ^a   Kaiser, Rolf ^a   Lübke, Nadine ^a   Thielen, Alexander ^b   Schuelter, Eugen ^a   Heger, Eva ^a   Däumer, Martin ^c   Reuter, Stefan ^d   Esser, Stefan ^e   Fätkenheuer, Gerd ^a   Pfister, Herbert ^a   Oette, Mark ^f   Lengauer, Thomas ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^c Institute for Immune genetics   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f Department of General Medicine Gastroenterology and Infectious Diseases Augustinerinnen Hospital   (Germany)

Author keywords

Coreceptor; Coreceptor antagonist; HIV 1; Immunology; Issue 58; Maraviroc; MVC; Prediction of coreceptor usage; R5; Tropism; X4

Indexed keywords

EID: 83455163512     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3264     Document Type: Article

References (13)

1. Heger, E., Schuelter, E., Klimkait, T., Lengauer, T., Kaiser, R., Walter, H., & Sierra, S. European coreceptor proficiency panel test. In 9th European Workshop on HIV & Hepatitis Treatment Strategies & Antiviral Drug Resistance. Paphos, Cyprus (2011).
2. Lengauer, T., Sander, O., Sierra, S., Thielen, T., & Kaiser, R. Bioinformatic prediction of HIV coreceptor usage. Nature Biotech. 25 (12), 1407-1410 (2007).
3. McGovern, R., Dong, W., Zhong, X., Knapp, D., Thielen, A., Chapman, D., Lewis, M., James, I., Valdez, H., & Harrigan, P.R. Population-based Sequencing of the V3-loop Is Comparable to the Enhanced Sensitivity Trofile Assay in Predicting Virologic Response to Maraviroc of Treatment-naïve Patients in the MERIT Trial. In 17th Conference on Retroviruses and Opportunistic Infections. San Francisco, USA, (2010).
4. Reuter, S., Braken, P., Jensen, B., Sierra-Aragon, S., Oette, M., Balduin, M., Kaiser, R., & Haussinger, D. Maraviroc in treatment-experienced patients with HIV-1 infection - experience from routine clinical practice. Eur. J. Med. Res. 15 (6), 231-237 (2010).
5. Recordon-Pinson, P., Soulie, C., Flandre, P., Descamps, D., Lazrek, M., Charpentier, C., Montes, B., Trabaud, M.A., Cottalorda, J., Schneider, V., Morand-Joubert, L., Tamalet, C., Desbois, D., Mace, M., Ferre, V., Vabret, A., Ruffault, A., Pallier, C., Raymond, S., Izopet, J., Reynes, J., Marcelin, A.G., & Masquelier, B. Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study. Antimicrob. Agents. Chemother. 54 (8), 3335-3340 (2010).
6. Swenson, L.C., Knapp, D., & Harrigan, P.R. Calibration and accuracy of the geno2pheno co-receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotype. In 10th International Congress on Drug Therapy in HIV Infection 2010. Glasgow, UK, Journal of the International AIDS Society., (2010).
7. Macartney, M.J., Cameron, J., Strang, A., GarcÍa, A., Booth, C., Marshall, N., Johnson, M., & Geretti, A.M. Use of a genotypic assay for the prediction of HIV-1 coreceptor tropism and guiding the use of CCR5 antagonists in clinical practice. in 8th European HIV Drug Resistance Workshop. Sorrento, Italy, (2010).
8. Sierra, S., Thielen, A., Reuter, S., Jensen, B., Esser, S., Fätkenheuer, G., Lengauer, T., Pfister, H., Sichtig, N., & Kaiser, R. Tropism determination and clinical outcome of 61 patients under MVC treatment. in 8th European HIV Drug Resistance Workshop. Sorrento, Italy, (2010).
9. Obermeier, M., Carganico, A., Bieniek, B., Schleehauf, D., Dupke, S., Fischer, K., Freiwald, M., Neifer, S., Schuler, C., Mayr, C., Klausen, G., Ko ppe, S., üu nsche, T., Berg, T., & Baumgarten, A. Tropism testing from proviral DNA - analysis of a subgroup from the Berlin Maraviroc cohort. In 8th European HIV Drug Resistance Workshop. Sorrento, Italy, (2010).
10. Vandekerckhove, L.P., Wensing, A.M., Kaiser, R., Brun-Vezinet, F., Clotet, B., De Luca, A., Dressler, S., Garcia, F., Geretti, A.M., Klimkait, T., Korn, K., Masquelier, B., Perno, C.F., Schapiro, J.M., Soriano, V., Sonnerborg, A., Vandamme, A.M., Verhofstede, C., Walter, H., Zazzi, M., & Boucher, C.A. European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis. 11 (5), 394-407 (2011).
11. Walter, H., Eberle, J., Möller, H., Noah, C., Wolf, E., Stürmer, M., Braun, P., Krn, K., Däumer, M., Berg, T., Obermeier, M., Thielen, A., & Kaiser, R. Empfehlung zur Bestimmung des HIV-1-Korezeptor-Gebrauchs (DAIG Recommendations for the HIV-1 tropism testing). [cited 2011 May, 15], Available from: http://www.daignet.de/site-content/hiv-therapie/leitlinien1/Leitlinien%20zur%20Topismus_Testung%20Stand%20Juni%202009.pdf (2010).
12. Obermeier, M.J., Carganico, A., Dupke, S., Schranz, D., Cordes, C., Freiwald, M., Klausen, G., Köppe, S., Schuler, C., Mayr, C., Schleehauf, D., Berg, T., Krznaric, I., & Baumgarten, A. Clinical application of genotypic co-receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort. Journal of the International AIDS Society. 13 (Suppl. 4), P129 (2010).
13. Toma, J., Frantzell, A., Hoh, R., Martin, J., Deeks, S., Petropoulos, C., & Huang, W. Determining HIV-1 Co-receptor Tropism Using PBMC Proviral DNA Derived from Aviremic Blood Samples. In 18th Conference on Retroviruses and Opportunistic Infections. San Francisco, USA, (2010).